Axis Bank, Max Financial shares in focus after clarification on Swamy’s allegation
Both the companies have refuted Subramanian Swamy’s allegation, saying that they obtained all necessary regulatory approvals for the Axis Bank-Max Life deal.
Both the companies have refuted Subramanian Swamy’s allegation, saying that they obtained all necessary regulatory approvals for the Axis Bank-Max Life deal.
Swamy has alleged that the Axis Bank-Max Life deal violated the mandatory directions of the IRDAI.
The share price of the life insurance company gained as much as 6.3% to touch a new 52-week high of ₹937.50 in early trade today.